Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination
- 31 May 2022
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (5)
Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: We aim to assess population‐level effects of human papillomavirus (HPV) vaccination programmes on HPV‐related disease and harms from vaccination.Keywords
This publication has 41 references indexed in Scilit:
- Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA StudyPLOS ONE, 2013
- Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminataVirology Journal, 2013
- Systematic review of the incidence and prevalence of genital wartsBMC Infectious Diseases, 2013
- Genital warts and cost of care in EnglandSexually Transmitted Infections, 2011
- The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UKSexually Transmitted Infections, 2011
- Incident Cervical HPV Infections in Young Women: Transition Probabilities for CIN and Infection ClearanceCancer Epidemiology, Biomarkers & Prevention, 2011
- Human papillomavirus vaccinesReviews in Medical Virology, 2006
- Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the USPharmacoEconomics, 2005
- A REPORT FROM NEW ZEALAND:AN "UNFORTUNATE EXPERIMENT"Bioethics, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986